Sort by
Fundamental Study for AI-Based Impact Analysis of Structural Elements in Wooden Structures
Tokikatsu Namba
Posted: 31 December 2025
Quantification of In Vitro Replicative Lifespan Elongation Activity of Hormones, Antioxidants, Plant Extract and Bacterial Exudate by Updated “Overlay Method”
Hiroshi Sakagami
,Alejandro Mena Acra
,Tetsuro Harada
,Fuminori Iwasa
,Masayo Abe
,Megumi Inomata
,Hideki Aoyagi
,Takao Tsukahara
,Kenjiro Bandow
,Hiroshi Kadokura
+2 authors
Posted: 31 December 2025
Evaluating Measurement Uncertainty Using Models with Arguments Subject to a Constraint
Adriaan M.H. van der Veen
,Gertjan Kok
,Kjetil Folgerø
Posted: 31 December 2025
Sustainability-Focused Evaluation of Self-Compacting Concrete: Integrating Explainable Machine Learning and Mix Design Optimization
Abdulaziz Aldawish
,Sivakumar Kulasegaram
Posted: 31 December 2025
Environmental Drivers of Waterbird Colonies Dynamic in the Danube Delta Biosphere Reserve Under the Context of Climate and Hydrological Change
Constantin Ion
,Vasile Jitariu
,Lucian Eugen Bolboaca
,Pavel Ichim
,Mihai Marinov
,Vasile Alexe
,Alexandru Doroșencu
Posted: 31 December 2025
Curative Approach to the Treatment of Beta-Thalassemia and Sickle Cell Disease with Hematopoietic Stem Cell Transplantation
Ugo Testa
,Germana Castelli
,Elvira Pelosi
b-thalassemia and sickle cell disease are two inherited hematological diseases due to defective hemoglobin synthesis or to the production of hemoglobin with altered properties. These two conditions have prolonged survival with modern support therapies, albeit life-long, complex, expensive and resources-consuming. Studies carried out in the last three decades have shown that allogeneic hematopoietic stem cell transplantation (allo-HSCT) and gene therapy may offer a curative approach for these diseases. Allo-HSCT should be performed early in life to reduce disease-related complications like irreversible tissue damage due to iron overload in patients with transfusion-dependent b-thalassemia (TDT) and systemic vasculopathy in patients with sickle cell disease (SCD). HSCTs from a matched-sibling donor or a matched-unrelated donor represent the best therapeutic option; however, haplo-identical HSCT in both TDT and SCD is now increasingly performed as a valuable and viable option for a larger number of these patients. An alternative curative strategy is based on gene therapy. These curative approaches, particularly those of gene therapy, are available only in a part of the world. Gene therapy diffusion is strongly limited by its high technological and infrastructure requirements and its very high cost. Criteria must be defined for the optimal selection of TDT and SCD patients for allo-HSCT or gene therapy.
b-thalassemia and sickle cell disease are two inherited hematological diseases due to defective hemoglobin synthesis or to the production of hemoglobin with altered properties. These two conditions have prolonged survival with modern support therapies, albeit life-long, complex, expensive and resources-consuming. Studies carried out in the last three decades have shown that allogeneic hematopoietic stem cell transplantation (allo-HSCT) and gene therapy may offer a curative approach for these diseases. Allo-HSCT should be performed early in life to reduce disease-related complications like irreversible tissue damage due to iron overload in patients with transfusion-dependent b-thalassemia (TDT) and systemic vasculopathy in patients with sickle cell disease (SCD). HSCTs from a matched-sibling donor or a matched-unrelated donor represent the best therapeutic option; however, haplo-identical HSCT in both TDT and SCD is now increasingly performed as a valuable and viable option for a larger number of these patients. An alternative curative strategy is based on gene therapy. These curative approaches, particularly those of gene therapy, are available only in a part of the world. Gene therapy diffusion is strongly limited by its high technological and infrastructure requirements and its very high cost. Criteria must be defined for the optimal selection of TDT and SCD patients for allo-HSCT or gene therapy.
Posted: 31 December 2025
Efficacy of a Naturally Calcium- and Magnesium-Rich Mineral Water on Musculoskeletal Fragility: A Randomized, Double-Blind Controlled Trial
Antimo Moretti
,Sara Liguori
,Marco Paoletta
,Francesca Gimigliano
,Giovanni Iolascon
Background/Objectives: Calcium and magnesium are essential minerals involved in neuromuscular function, bone metabolism, and fall prevention. Deficiency of these minerals contributes to musculoskeletal fragility, including osteoporosis, sarcopenia, and falls. While dairy products are the traditional source of dietary calcium, mineral waters naturally rich in calcium and magnesium offer a highly bioavailable alternative. This study evaluated the efficacy of daily intake of a naturally calcium‑ and magnesium‑rich mineral water compared with low-mineral water on fall risk, muscle mass, and muscle function in adults aged ≥50 years, with or without osteosarcopenia. Methods: In this 12‑month, randomized, double‑blind, controlled trial, 98 participants were assigned to consume 1 L/day of either SG9 (mineral water with high calcium and magnesium content) or J66 (low-mineral water). Outcomes included incidence of falls (primary endpoint), appendicular skeletal muscle mass (ASMM), muscle strength, physical performance, biochemical markers, and patient-reported measures. Assessments were performed at baseline, 6 months, and 12 months following CONSORT guidelines. Results: Ninety-eight participants (mean age ~63 years) were randomized and completed the 12-month follow-up. At 6 months, the incidence of falls was significantly lower in the SG9 group compared with the J66 group (relative risk reduction 82%; RR = 0.18, 95% CI 0.04–0.88; p < 0.05), whereas no significant between-group difference was observed at 12 months. Appendicular skeletal muscle mass indexed to height (ASMM/h²) was significantly higher in the SG9 group at 12 months (p = 0.005). In participants with osteosarcopenia, SG9 intake was associated with a consistent improvement in ASMM/h² at 6 and 12 months (p = 0.012 and p = 0.005, respectively). No significant between-group differences were detected in physical performance scores, biochemical markers, or quality-of-life measures. Conclusions: Daily consumption of calcium- and magnesium rich mineral water reduced fall risk and improved muscle mass in adults over 50 years, with or without osteosarcopenia. These findings support the role of calcium- and magnesium-rich mineral water as a complementary nutritional strategy for musculoskeletal health and fragility prevention.
Background/Objectives: Calcium and magnesium are essential minerals involved in neuromuscular function, bone metabolism, and fall prevention. Deficiency of these minerals contributes to musculoskeletal fragility, including osteoporosis, sarcopenia, and falls. While dairy products are the traditional source of dietary calcium, mineral waters naturally rich in calcium and magnesium offer a highly bioavailable alternative. This study evaluated the efficacy of daily intake of a naturally calcium‑ and magnesium‑rich mineral water compared with low-mineral water on fall risk, muscle mass, and muscle function in adults aged ≥50 years, with or without osteosarcopenia. Methods: In this 12‑month, randomized, double‑blind, controlled trial, 98 participants were assigned to consume 1 L/day of either SG9 (mineral water with high calcium and magnesium content) or J66 (low-mineral water). Outcomes included incidence of falls (primary endpoint), appendicular skeletal muscle mass (ASMM), muscle strength, physical performance, biochemical markers, and patient-reported measures. Assessments were performed at baseline, 6 months, and 12 months following CONSORT guidelines. Results: Ninety-eight participants (mean age ~63 years) were randomized and completed the 12-month follow-up. At 6 months, the incidence of falls was significantly lower in the SG9 group compared with the J66 group (relative risk reduction 82%; RR = 0.18, 95% CI 0.04–0.88; p < 0.05), whereas no significant between-group difference was observed at 12 months. Appendicular skeletal muscle mass indexed to height (ASMM/h²) was significantly higher in the SG9 group at 12 months (p = 0.005). In participants with osteosarcopenia, SG9 intake was associated with a consistent improvement in ASMM/h² at 6 and 12 months (p = 0.012 and p = 0.005, respectively). No significant between-group differences were detected in physical performance scores, biochemical markers, or quality-of-life measures. Conclusions: Daily consumption of calcium- and magnesium rich mineral water reduced fall risk and improved muscle mass in adults over 50 years, with or without osteosarcopenia. These findings support the role of calcium- and magnesium-rich mineral water as a complementary nutritional strategy for musculoskeletal health and fragility prevention.
Posted: 31 December 2025
Family Members’ Experiences of Long-Term Home Care for Older Adults Provided by Live-In Migrant Caregivers: A Meta-Synthesis of Qualitative Studies
Sandra Aliaga-Castellanos
,Sergio Martinez-Granero
,Alba Fernández-Férez
,José Granero-Molina*
,Laura Helena Antequera-Raynal
,Gonzalo Granero-Heredia
,María del Mar Jiménez-Lasserrotte
Posted: 30 December 2025
Post-Orgasmic Illness Syndrome: Clinical Presentation, Psychosocial Impact, and Management Challenges Based on Two Case Reports
Andreia Salgado Gonçalves
,Rodrigo Cruz Santos
,Sara Serra
,Pedro Teixeira
Posted: 30 December 2025
Comprehensive Insight into Sugar Transporters of Candidozyma Auris and Their Roles in Antifungal Resistance
Praveen Kumar
,Mohit Kumar
,Amandeep Saini
,Sheikh Owais Mohamad
,Basharat Ali
,Brooke D. Esquivel
,Atanu Banerjee
,Theodore C White
,Naseem A Gaur
,Abdul Haseeb Shah
+2 authors
Posted: 30 December 2025
Graph-Based Phishing Domain Detection via Certificate–DNS Heterogeneous Networks
Luca Bianchi
,Elena Rossi
,Luca Ferraro
Posted: 30 December 2025
Effect of Post-Sintering Shot Peening Treatment on the Corrosion Behavior of Alumix 321 Powder Metallurgy Alloy in 3.5 wt.% NaCl Solution
Abdulwahab Ibrahim
,Paul Bishop
,Georges Kipouros
Posted: 30 December 2025
Injectable Porcine Collagen for Achilles Tendinopathy in Diabetic Patients: A Case Series with Data-Driven Analysis
Giacomo Placella
,Nicolò Giuseppe Biavardi
,Mattia Alessio Mazzola
,Vincenzo Salini
Posted: 30 December 2025
Epigenetic and Metabolic Reprogramming in Autoimmune Rheumatology: Toward Next-Generation Immune Regulation
Ola Al Ewaidat
,Moawiah Naffaa
Posted: 30 December 2025
Cross-Domain Semantic-Enhanced Adaptive Graph Fusion Network for Robust Skeleton Action Recognition
Zeren Gu
,Jialei Tan
Posted: 30 December 2025
Educational AI: Automated Computational Thinking Assessment from Visual Programming Artifacts
Apeksha Bhuekar
Posted: 30 December 2025
Drone-Based Road Marking Condition Mapping: A Drone Imaging and Geospatial Pipeline for Asset Management
Minh Dinh Bui
,Jubin Lee
,Kanghyeok Choi
,HyunSoo Kim
,Changjae Kim
Posted: 30 December 2025
Effects of Continuous versus Interval Aerobic Training Combined with Resistance Exercise on Short-Term Blood Pressure Variability in Patients with Ischemic Heart Disease
Matteo Vitarelli
,Camilla Calandri
,Giuseppe Caminiti
,Maurizio Volterrani
,Ferdinando Iellamo
,Marco Alfonso Perrone
,Domenico Mario Giamundo
,Giuseppe Marazzi
,Bruno Ruscello
,Elvira Padua
+2 authors
Posted: 30 December 2025
Wearable Sensors for Health Monitoring
Caroline Abreu
,Carla Bédard
,Jean-Christophe Lourme
,Benoit Piro
Posted: 30 December 2025
Sulforaphane in Cancer Prevention and Therapy: From Epidemiology to Molecular Mechanisms and Translational Perspectives
Jung Yoon Jang
,Donghwan Kim
,Na Kyeong Lee
,Eunok Im
,Nam Deuk Kim
Posted: 30 December 2025
of 5,399